Safety first for Arriello

Pharmacovigilance (PV) solutions and services provider, Arriello (www.arriello.com) is adopting Veeva Vault Safety™ (www.veeva.com/products/vault-safety) as part of the company’s continued growth in pharmacovigilance operations.

Safety databases are a requirement for fast assessment of data, processing of safety information such as SUSARs and ICSRS, aggregate report production, signal management, and management of safety compliance documentation such as PSMF.

Vault Safety will be part of Arriello’s fast-growing expert pre- and post-marketing authorization pharmacovigilance, compliance, and drug safety services.

“Veeva is disrupting the market dominance and status quo enjoyed by the major database players for some time now. Together with our own moves into PV automation, Vault Safety helps position Arriello as the leader of this exciting wave of change,” says Anna Lukyanova, Arriello’s Chief Operating Officer. “It also fits with our own profile as a challenger and disrupter in the managed PV and regulatory information services market.”

“There are growing expectations for pharmacovigilance organizations to collect, manage, and analyze an increasing amount of data,” said Jennifer Markey, vice president of safety strategy and business consulting, Europe at Veeva Systems.  “Veeva Vault Safety gives companies a modern application to manage adverse event information and documentation.  We look forward to working with Arriello to support the needs of the pharmacovigilance industry.”

Arriello will also offer pharmacovigilance migration and configuration services and a complementary front-end data collection add-on tool to Vault Safety called IntelliCASE.

Arriello’s IntelliCASE allows field-based drug reps and other reporters to readily submit adverse event data to a safety database in real time via their mobile devices, ensuring that more PV information is captured promptly and accurately.